Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Latest action · Oct 18, 2011 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 14, 2011
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions related to financial interests of Food and Drug Administration (FDA) advisory committee members to require the Secretary of Health and Human Services (HHS) to ensure that individual appointments to advisory committees are made to promote scientific and technical expertise while at the same time minimizing any potential conflicts of interest. Requires the Secretary to consider, with respect to any financial interest constituting a potential conflict of interest, the type, nature, and magnitude of the financial interest. Declares that no specific factor shall be dispositive in the Secretary's evaluation of a particular financial interest.
Repeals the prohibition specifically applicable to FDA that prevents a member of an advisory committee from participating with respect to a particular matter if such individual or an immediate family member of such individual has a financial interest that could be affected by the advice given to the Secretary.
Cosponsors 15
Members who signed on, in the order they did. Signatures ran from Oct 14, 2011 to Jan 31, 2012; 8 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-LA | Bill Cassidy | Original | Oct 14, 2011 |
| R-KY | Brett Guthrie | Original | Oct 14, 2011 |
| R-CA | Brian P. Bilbray | Original | Oct 14, 2011 |
| R-MN | Erik Paulsen | Original | Oct 14, 2011 |
| R-IL | John Shimkus | Original | Oct 14, 2011 |
| R-TN | Marsha Blackburn | Original | Oct 14, 2011 |
| R-GA | Phil Gingrey | Original | Oct 14, 2011 |
| R-OH | Robert E. Latta | Original | Oct 14, 2011 |
| R-TX | John Abney Culberson | Oct 27, 2011 | |
| R-OR | Greg Walden | Nov 3, 2011 | |
| R-IN | Larry Bucshon | Dec 13, 2011 | |
| R-TX | Michael T. McCaul | Dec 16, 2011 | |
| R-IN | Todd Rokita | Jan 24, 2012 | |
| D-UT | Jim Matheson | Jan 31, 2012 | |
| D-GA | John Barrow | Jan 31, 2012 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 14, 2011 |
| Health Subcommittee | Referred Oct 18, 2011 |
Actions 3
Everything that happened, newest first.
- Oct 18, 2011Referred to the Subcommittee on Health.
- Oct 14, 2011Introduced in House
- Oct 14, 2011Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the page H6977.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act with respect to appointments to advisory committees and conflicts of interest.
- Short Titles as Introduced
- Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Oct 14, 2011Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.